74 related articles for article (PubMed ID: 29711662)
1. Biosynthesis of Psoralen: Mechanism of a Cytochrome P450 Catalyzed Oxidative Bond Cleavage.
Stanjek V; Miksch M; Lueer P; Matern U; Boland W
Angew Chem Int Ed Engl; 1999 Feb; 38(3):400-402. PubMed ID: 29711662
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and functional characterization of psoralen synthase, the first committed monooxygenase of furanocoumarin biosynthesis.
Larbat R; Kellner S; Specker S; Hehn A; Gontier E; Hans J; Bourgaud F; Matern U
J Biol Chem; 2007 Jan; 282(1):542-54. PubMed ID: 17068340
[TBL] [Abstract][Full Text] [Related]
3. Elicitor-induced biosynthesis of psoralens in Ammi majus L. suspension cultures. Microsomal conversion of demethylsuberosin into (+)marmesin and psoralen.
Hamerski D; Matern U
Eur J Biochem; 1988 Jan; 171(1-2):369-75. PubMed ID: 2828055
[TBL] [Abstract][Full Text] [Related]
4. Differential response of cultured parsley cells to elicitors from two non-pathogenic strains of fungi. Microsomal conversion of (+)marmesin into psoralen.
Wendorff H; Matern U
Eur J Biochem; 1986 Dec; 161(2):391-8. PubMed ID: 3023094
[TBL] [Abstract][Full Text] [Related]
5. A new P450 involved in the furanocoumarin pathway underlies a recent case of convergent evolution.
Villard C; Munakata R; Kitajima S; van Velzen R; Schranz ME; Larbat R; Hehn A
New Phytol; 2021 Sep; 231(5):1923-1939. PubMed ID: 33978969
[TBL] [Abstract][Full Text] [Related]
6. Isolation and functional characterization of CYP71AJ4 encoding for the first P450 monooxygenase of angular furanocoumarin biosynthesis.
Larbat R; Hehn A; Hans J; Schneider S; Jugdé H; Schneider B; Matern U; Bourgaud F
J Biol Chem; 2009 Feb; 284(8):4776-85. PubMed ID: 19098286
[TBL] [Abstract][Full Text] [Related]
7. Rate-limiting steps in cytochrome P450 catalysis.
Guengerich FP
Biol Chem; 2002 Oct; 383(10):1553-64. PubMed ID: 12452431
[TBL] [Abstract][Full Text] [Related]
8. Bio-activation of 4-alkyl analogs of 1,4-dihydropyridine mediated by cytochrome P450 enzymes.
Li XX; Zhang X; Zheng QC; Wang Y
J Biol Inorg Chem; 2015 Jun; 20(4):665-73. PubMed ID: 25783494
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-catalyzed O-dealkylation coupled with photochemical NADPH regeneration.
Lee SH; Kwon YC; Kim DM; Park CB
Biotechnol Bioeng; 2013 Feb; 110(2):383-90. PubMed ID: 23007262
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-catalyzed dealkylation of atrazine by Rhodococcus sp. strain NI86/21 involves hydrogen atom transfer rather than single electron transfer.
Meyer AH; Dybala-Defratyka A; Alaimo PJ; Geronimo I; Sanchez AD; Cramer CJ; Elsner M
Dalton Trans; 2014 Aug; 43(32):12175-86. PubMed ID: 24851834
[TBL] [Abstract][Full Text] [Related]
11. Theoretical study of N-dealkylation of N-cyclopropyl-N-methylaniline catalyzed by cytochrome P450: insight into the origin of the regioselectivity.
Li D; Wang Y; Yang C; Han K
Dalton Trans; 2009 Jan; (2):291-7. PubMed ID: 19089010
[TBL] [Abstract][Full Text] [Related]
12. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
Labroo RB; Thummel KE; Kunze KL; Podoll T; Trager WF; Kharasch ED
Drug Metab Dispos; 1995 Apr; 23(4):490-6. PubMed ID: 7600917
[TBL] [Abstract][Full Text] [Related]
13. Psoralen, a mechanism-based inactivator of CYP2B6.
Ji L; Lu D; Cao J; Zheng L; Peng Y; Zheng J
Chem Biol Interact; 2015 Oct; 240():346-52. PubMed ID: 26335194
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
15. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
16. Probing the active site of cytochrome P450 2B1: metabolism of 7-alkoxycoumarins by the wild type and five site-directed mutants.
Kobayashi Y; Fang X; Szklarz GD; Halpert JR
Biochemistry; 1998 May; 37(19):6679-88. PubMed ID: 9578551
[TBL] [Abstract][Full Text] [Related]
17. Novel metabolic pathway of arylethers by cytochrome P450: cleavage of the oxygen-aromatic ring bond accompanying ipso-substitution by the oxygen atom of the active species in cytochrome P450 models and cytochrome P450.
Ohe T; Mashino T; Hirobe M
Arch Biochem Biophys; 1994 May; 310(2):402-9. PubMed ID: 8179325
[TBL] [Abstract][Full Text] [Related]
18. Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes.
Bolleddula J; Chowdhury SK
Drug Metab Rev; 2015; 47(4):534-57. PubMed ID: 26390887
[TBL] [Abstract][Full Text] [Related]
19. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
20. Engineering cytochrome P450 monooxygenase CYP 116B3 for high dealkylation activity.
Liu L; Schmid RD; Urlacher VB
Biotechnol Lett; 2010 Jun; 32(6):841-5. PubMed ID: 20213524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
